Federal vaccine advisors handpicked by Health Secretary Robert F. Kennedy Jr have made a move that has left public health experts and medical professionals reeling. The advisory committee on immunization practices, or ACIP, voted to scrap the universal recommendation for the hepatitis B vaccine at birth, citing no evidence of harm from a single dose.
The decision was met with widespread criticism, as studies and historical data suggest it will lead to more infections in babies and ultimately, an increased risk of chronic liver disease, liver cancer, and premature death. Cody Meissner, a pediatrician and member of the ACIP panel, expressed his opposition to the change, stating that "we have heard 'do no harm' is a moral imperative. We are doing harm by changing this [recommendation]."
The move comes after years of attempts to modify or eliminate the universal recommendation for the birth dose, which has been in place since 1991. The original recommendation was made following a 37 percent increase in infected infants between 1979 and 1989. Since its implementation, infections have largely disappeared.
However, there is no evidence to support delaying the vaccine until the first month of life or even beyond that. In fact, experts have warned that this could open a window for babies to be infected with hepatitis B by mothers who had false-negative test results or others they come into contact with in the early months of life.
The altered recommendation now suggests that parents and healthcare providers should use "individual-based decision making" when it comes to administering the vaccine. If they decide to delay, the panel recommends giving the first dose "no earlier than 2 months of age."
Critics argue that this opens up a Pandora's box for confusion among parents and increases the risk of hepatitis B infection in vulnerable populations. Medical experts have denounced the vote as "reckless" and an "undermining" of decades of public trust in a proven lifesaving vaccine.
The decision is being met with frustration from many quarters, including medical professionals who point out that there is no data to support this new recommendation. Sandra Adamson Fryhofer, a board member of the American Medical Association, stated that today's action "is not based on scientific evidence and disregards decades of public confidence in a proven, lifesaving vaccine."
The decision was met with widespread criticism, as studies and historical data suggest it will lead to more infections in babies and ultimately, an increased risk of chronic liver disease, liver cancer, and premature death. Cody Meissner, a pediatrician and member of the ACIP panel, expressed his opposition to the change, stating that "we have heard 'do no harm' is a moral imperative. We are doing harm by changing this [recommendation]."
The move comes after years of attempts to modify or eliminate the universal recommendation for the birth dose, which has been in place since 1991. The original recommendation was made following a 37 percent increase in infected infants between 1979 and 1989. Since its implementation, infections have largely disappeared.
However, there is no evidence to support delaying the vaccine until the first month of life or even beyond that. In fact, experts have warned that this could open a window for babies to be infected with hepatitis B by mothers who had false-negative test results or others they come into contact with in the early months of life.
The altered recommendation now suggests that parents and healthcare providers should use "individual-based decision making" when it comes to administering the vaccine. If they decide to delay, the panel recommends giving the first dose "no earlier than 2 months of age."
Critics argue that this opens up a Pandora's box for confusion among parents and increases the risk of hepatitis B infection in vulnerable populations. Medical experts have denounced the vote as "reckless" and an "undermining" of decades of public trust in a proven lifesaving vaccine.
The decision is being met with frustration from many quarters, including medical professionals who point out that there is no data to support this new recommendation. Sandra Adamson Fryhofer, a board member of the American Medical Association, stated that today's action "is not based on scientific evidence and disregards decades of public confidence in a proven, lifesaving vaccine."